TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06775444

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Breastfeeding Education Program Based on Planned Behavior Theory
Description: In addition to routine breastfeeding training at the hospital where the study is conducted, the intervention group will be given a 2-session Breastfeeding Training Program Based on Planned Behavior Theory.~Education Content:~The importance of breast milk, the benefits of breastfeeding, the dangers of artificial feeding, putting the baby to the breast, signs of hunger in the baby, the harms of bottle and pacifier, breastfeeding positions, breast-related problems, information sources about breastfeeding, birth and breastfeeding leave for working mothers, breastfeeding in the community, the importance of environmental and professional support during breastfeeding. Insufficient milk anxiety, increasing milk intake and production, situations where milk should be expressed, milk expression methods, storage conditions of breast milk, alternative feeding methods with expressed milk, methods to be applied to increase breast milk, differences between breast milk and formula milk.

Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Routine Breastfeeding Training
Description: The control group will receive routine breastfeeding education at the hospital where the study is conducted. Routine breastfeeding education includes the importance of breast milk and breastfeeding (benefits of breast milk and breastfeeding, correct breastfeeding technique and breastfeeding positions, time for the first feeding of the newborn, feeding method, expressing and storing breast milk, techniques for giving expressed breast milk as close as possible to breastfeeding, harms of bottle use, breast problems and coping methods). Pregnant women who give birth at the hospital where the study is conducted receive routine breastfeeding education from the breastfeeding nurse in the ward before being discharged.
Study: NCT06775509

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ortho-K
Description: Utilization of Ortho-K Contact Lenses for The Treatment of Myopia
Study: NCT06776328

Intervention type: OTHER
Group type: OTHER
Intervention: Tools
Description: In the co-creation meetings, developed tools will be presented. Participants will be asked to provide feedback and input to tailor these tools to the needs and preferences of children and adolescents with suicidal thoughts/behavior.
Study: NCT06776315

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Resistive threshold inspiratory muscle training device
Description: In the other arm of the study, respiratory muscle training is performed in addition to the standard pulmonary rehabilitation program. Respiratory muscle strengthening training is performed with a resistive thereshold inspiratory muscle strengthening device. The exercise is performed at an intensity of 30% of the maximum inspiratory pressure determined by mouth pressure measurement. The exercise is performed in 7 sets, with 2 minutes of work and 1 minute break for a total of 21 minutes.
Study: NCT06319989

Intervention type: OTHER
Group type: OTHER
Intervention: Biplane Ultrasound
Description: During a standard of care caudal epidural block, biplane ultrasound will be used.

Intervention type: OTHER
Group type: OTHER
Intervention: Single plane ultrasound
Description: During a standard of care caudal epidural block, single plane ultrasound will be used.
Study: NCT06776315

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard pulmonary rehabilitation programme
Description: Patients are asked to perform thoracic, diaphragmatic breathing, and lower basal breathing exercises with 10 repetitions. Then, strengthening exercises are performed on the major muscle groups of the upper and lower extremities. In accordance with the resistance training program in the ATS/ERS guidelines for pulmonary rehabilitation, two to four sets of 6-12 repetitions are performed with intensities ranging from 50% to 85% of one maximum repetition, two to three times a week. During the exercises, the patient is questioned about their fatigue and dyspnea levels using the Borg scale, and breaks are given when necessary. The aerobic exercise program is performed as a 12-week, 3-day-a-week self-walking exercise. The walking program is performed in the form of walking on flat ground at 60% workload, based on the data obtained from the 6-minute walking test result (land-based walking).

Intervention type: OTHER
Group type: OTHER
Intervention: No intervention
Description: Peripheral blood samples will be taken once from the participants in the control group and no other intervention will be performed.
Study: NCT06775756

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: IMRT with reduced-dose and reduced-volume cervical prophylactic irradiation
Description: For N0 disease, only cover bilateral RPN and level II. For N1 disease, cover ipsilateral involved level plus subsequent level downword, and cover contralateral level RPN and level II. For N2 disease, cover ipsilateral involved level plus subsequent level downword. For N3 disease, cover ipsilateral involved level plus subsequent level downword, and ensuring a 2cm margin below GTVn if GTVn reach or near the sternoclavicular joint. Notably, for unilateral N3, the contralateral neck would only include RPN and level II. Prescribing dose for CTVn2 was 50Gy/33Fx.
Study: NCT05973071

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tuune Supplemented Contraceptive Visit
Description: Participants complete the Tuune contraceptive decision aid health questionnaire (Tuune for clinics) as part of their standard OBGYN clinic appointment.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Traditional Contraceptive Visit
Description: Participants will complete a standard OBGYN clinic appointment without using the Tuune contraceptive decision aid health questionnaire (Tuune for Clinics).
Study: NCT06549595

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD0486
Description: a fully human bispecific monoclonal IgG4 antibody

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD0486
Description: a fully human bispecific monoclonal IgG4 antibody

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: R-CHOP
Description: Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone
Study: NCT05493111

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AR-15512 Ophthalmic Solution
Description: Topical ocular administration of one drop in both eyes BID for 365 days.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle
Description: Topical ocular administration of one drop in both eyes BID for 365 days.
Study: NCT06107088

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Active 1
Description: lactase enzyme

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Active 1
Description: lactase enzyme

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Active 2
Description: lactase-bacterial strain combination

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Active 3
Description: bacterial strain alone

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: placebo

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Placebo
Description: placebo
Study: NCT05208411

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Project ImPACT: Improving Parents As Communication Teachers
Description: Project ImPACT (Improving Parents As Communication Teachers, Ingersoll \& Dvortcsak, 2019) is a promising evidence-based parent-mediated intervention that is part of a class of naturalistic, developmental, behavioral interventions (NBDIs). NBDIs involve the use of behavioral principles of learning to teach skills chosen from a developmental sequence in naturalistic play-setting and using natural rewards. Skills selected as relevant for intervention are those that allow the child to participate more fully within reciprocal interactions with the adult. In recent years the program has been adapted for use with infants and toddlers at elevated likelihood of ASD. These adaptations have made this program appropriate for younger children and children who are experiencing social communication delays but do not have an ASD diagnosis.
Study: NCT05631899

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: KRAS-EphA-2-CAR-DC
Description: 5\~10 × 10\^6 CAR-DCs per dose will be administered by intravenous injection.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: KRAS-EphA-2-CAR-DC
Description: 5\~10 × 10\^6 CAR-DCs per dose will be administered by intravenous injection.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: KRAS-EphA-2-CAR-DC
Description: 5\~10 × 10\^6 CAR-DCs per dose will be administered by intravenous injection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Abraxane
Description: Intravenous abraxane 125 mg/m\^2/day on day-5.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Abraxane
Description: Intravenous abraxane 125 mg/m\^2/day on day-5.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Abraxane
Description: Intravenous abraxane 125 mg/m\^2/day on day-5.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Intravenous cyclophosphamide 300 mg/m\^2/day on day -4.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Intravenous cyclophosphamide 300 mg/m\^2/day on day -4.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Intravenous cyclophosphamide 300 mg/m\^2/day on day -4.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anti-PD-1 antibody
Description: Intravenous anti-PD-1 antibody 200 mg/day.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anti-PD-1 antibody
Description: Intravenous anti-PD-1 antibody 200 mg/day.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anti-CTLA4 Monoclonal Antibody
Description: Intravenous anti-CTLA4 antibody 1 mg/kg/day
Study: NCT06564675

Intervention type: DIAGNOSTIC_TEST
Intervention: C-Trend Index
Description: C-trend-Index is collected blinded from the patients using Brainstatus device. The device shows and collects also cEEG. These are analyzed retrospectively after all study patients have their 6-month follow-up data collected. The intervention does not affect clinical management or decision-making.
Study: NCT05511324

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Questionnaires
Description: Participants will be asked to complete this assessment on your own time, and it should take about 40 minutes.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Caregiver Assessment
Description: These sessions will involve simulation-based, caregiving skill training, and your caregiver will be taught skills to help support you (such as feeding, hygiene, mobility, medication administration, and care coordination).
Study: NCT06549595

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: R-CVP
Description: Rituximab, Cyclophosphamide, Vincristine and Prednisone

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: BR
Description: Bendamustine, Rituximab
Study: NCT04942171

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Atrial fibrillation catheter ablation group
Description: 1. Pulmonary vein isolation~2. Additional treatment for lesions caused by non-pulmonary veins~3. Esophageal temperature monitoring to prevent damage to the esophagus~4. Evaluation of procedure time and radiofrequency ablation time~5. Evaluation of complications after the procedure~6. Rhythm follow-up after the procedure is conducted in accordance with the above study design.~7. Conduct a survey on cognitive function and emotion before and 12 months after the procedure

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Medical therapy group
Description: 1. Use of beta-blockers or calcium channel blockers for pulse rate control~2. Antiarrhythmic drugs are administered to patients with highly symptomatic atrial fibrillation symptoms even after pulse rate control.~3. If symptoms are not controlled even with antiarrhythmic drugs, electrical conversion to restore sinus rhythm.~4. To prevent cerebral infarction, maintain optimal anticoagulant therapy according to the risk score for cerebral infarction.~5. Conduct a questionnaire on cognitive function and emotion before and 12 months after the procedure
Study: NCT05613660

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Veg Collagen Peptide
Description: Mode of Usage: 1 scoop/sachet daily Route of Administration: Oral administration with a glassful (approx. 250 mL) of water

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Bovine Collagen Peptide
Description: Mode of Usage: 1 scoop/sachet daily Route of Administration: Oral administration with a glassful (approx. 250 mL) of water

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Fish | Marine Collagen Peptide
Description: Mode of Usage: 1 scoop/sachet daily Route of Administration: Oral administration with a glassful (approx. 250 mL) of water

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Chicken Collagen Peptide
Description: Mode of Usage: 1 scoop/sachet daily Route of Administration: Oral administration with a glassful (approx. 250 mL) of water
Study: NCT05576935

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stroop task
Description: The task is partitioned in 4 blocks of 360 stimuli and each word will be presented on screen in 34 point font for 1000 ms with an inter-stimulus interval based on their performance on the Stroop max test. This max test will be performed during the familiarization trial, and is divided in blocks of 96 stimuli. After each block, the accuracy (ACC) will be calculated. When ACC \> 85%, the difficulty of the Stroop task will be increased by decreasing the stimulus presentation time (SPT). If ACC \< 85%, this block will be considered as an 'error' and the subject must redo the block without changing the SPT. The first block will have a SPT of 1500 ms. When the required ACC is achieved, the SPT will decrease in the following order: 1100, 900, 800,... to determine the individualized cognitive load. When the subject makes 3 errors in a row, or 5 errors during the whole trial, the trial will end. The SPT of the last block will be considered as the maximum capacity of that individual.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Documentary
Description: In order to avoid under- and over-arousal, participants will have the opportunity to choose between several documentaries. The participants will also receive a list of the available documentaries (based on selections from Netflix and Disney+) after the familiarization trial so that the trial can go as smoothly as possible.
Study: NCT04729829

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Social and behaviour change communication
Description: Each SBC treatment community will receive nutrition content and learning through savings groups. The group members will participate in skill-building activities that promote five key behaviours about fish nutrition and household decision making on fish consumption as part of facilitated discussions, interactive learning sessions, and a video-based facilitated dialogue. Increased fish consumption through SBC mass attendance events through marketing of fish vendors, interactive learning, and edu-tainment competitions promoting fish consumption. SBC will raise awareness of the benefits of eating fish as part of a balanced diet, with a particular focus on pregnant and lactating mothers, and children under 5 years of age.
Study: NCT06204731

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise and environmental conditions
Description: Participants will engage in interval training and will reside and sleep at different altitudes for a period of 4 weeks. Aerobic and anaerobic capacity tests and an eccentric exercise test will be performed before and after the training intervention. Before and after the training program, somatic measurements will also be taken. Before and after the first and last workout, blood will be drawn for biochemical analysis.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise and environmental conditions
Description: Participants will engage in interval training and will reside and sleep at different altitudes for a period of 4 weeks. Aerobic and anaerobic capacity tests and an eccentric exercise test will be performed before and after the training intervention. Before and after the training program, somatic measurements will also be taken. Before and after the first and last workout, blood will be drawn for biochemical analysis.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise and environmental conditions
Description: Participants will engage in interval training and will reside and sleep at different altitudes for a period of 4 weeks. Aerobic and anaerobic capacity tests and an eccentric exercise test will be performed before and after the training intervention. Before and after the training program, somatic measurements will also be taken. Before and after the first and last workout, blood will be drawn for biochemical analysis.
Study: NCT04729829

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Social and behaviour change communication
Description: Each SBC treatment community will receive nutrition content and learning through savings groups. The group members will participate in skill-building activities that promote five key behaviours about fish nutrition and household decision making on fish consumption as part of facilitated discussions, interactive learning sessions, and a video-based facilitated dialogue. Increased fish consumption through SBC mass attendance events through marketing of fish vendors, interactive learning, and edu-tainment competitions promoting fish consumption. SBC will raise awareness of the benefits of eating fish as part of a balanced diet, with a particular focus on pregnant and lactating mothers, and children under 5 years of age.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Fish aggregating device
Description: This is a moored line attached to buoys in coastal waters that attracts oceanic fish to it, to make it easier for small-scale fishers to catch them using their existing gear and boats. This FAD will work to increase the catch rate and hence, the availability of fish for sale in upland community markets.
Study: NCT05294068

Intervention type: OTHER
Intervention: standard of care for patients with cognitive impairments
Description: clinical examination, radiological, biological and physiological examinations.

Intervention type: OTHER
Intervention: standard of care for patients with neuromotor impairments
Description: clinical examination, radiological, biological and physiological examinations.

Intervention type: OTHER
Intervention: standard of care for patients with sensory impairments
Description: clinical examination, radiological, biological and physiological examinations.
Study: NCT04729829

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Fish aggregating device
Description: This is a moored line attached to buoys in coastal waters that attracts oceanic fish to it, to make it easier for small-scale fishers to catch them using their existing gear and boats. This FAD will work to increase the catch rate and hence, the availability of fish for sale in upland community markets.
Study: NCT05547139

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Protocolized weaning of respiratory support
Description: The protocolized weaning aims to keep babies on CPAP for a longer period of time and will measure how long it takes babies to wean to 2L nasal cannula support or come off all support (room air, RA).
Study: NCT06636786

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclobenzaprine HCl
Description: TNX-102 SL (cyclobenzaprine HCl sublingual tablets) taken sublingually (under the tongue) in the ED and each day at bedtime for a total of 2 weeks.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo sublingual tablets taken sublingually (under the tongue) in the ED and each day at bedtime for a total of 2 weeks.
Study: NCT05091905

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Continuous Infusion of ropivacaine 0.2%
Description: Patients will receive a continuous infusion of Ropivacaine 0.2% (6 mL/hr popliteal-sciatic and 8 mL/hr infraclavicular, 4 mL patient controlled bolus with 30-minute lockout) will be initiated in the recovery room.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Titratable Automated Intermittent Boluses of ropivacaine 0.2%
Description: Patients will receive patient-titratable intermittent boluses of Ropivacaine 0.2% (8 mL popliteal-sciatic or 11 mL infraclavicular automated bolus every 120 minutes, 4 mL patient controlled bolus with 30-minute lockout). In addition, the infusion pump will be set in a pause mode that delays initiation of the automated bolus doses by 5 hours (this can be over-ridden by patients if they would like to initiate their perineural infusion earlier than 5 hours). Lastly, subjects will be able to titrate the volume of their automated bolus up or down within the range of 1-16 mL.
Study: NCT05749744

Intervention type: OTHER
Intervention: cardiac telerehabilitation program by videoconference
Description: * A video conference interview with an Adapted Physical Activity (APA) teacher before starting physical training~* Exercise training for 3 weeks via distance coaching~* Therapeutic patient education (TPE) workshops conducted remotely with 1 workshop per week.~* Medical follow-up via teleconsultation~* Psychological and/or dietetic follow-up if necessary.~* Final assessment at 1 month with evaluation of aerobic metabolism, functional evaluation and final shared educational assessment (BEP).~* Appointment with an association Cœur et Santé and Sport-Santé 42 or setting up of an individual physical activity
Study: NCT06349993

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Digital Intervention
Description: game-based digital intervention app

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Health Education
Description: traditional health education app